US Patent 7173039 Protein kinase inhibitors
Patent 7173039 was granted and assigned to Theravance on February, 2007 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 11, 2005
Date of Patent
February 6, 2007
Patent Application Number
11178736
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7173039 Protein kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.